Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 7 | 2023 | 989 | 1.600 |
Why?
|
| Ventral Tegmental Area | 8 | 2017 | 49 | 1.310 |
Why?
|
| Epilepsy | 3 | 2023 | 883 | 1.200 |
Why?
|
| Stress, Psychological | 14 | 2014 | 1000 | 1.190 |
Why?
|
| Depression | 9 | 2020 | 1715 | 1.010 |
Why?
|
| Nucleus Accumbens | 13 | 2012 | 61 | 0.920 |
Why?
|
| Neurobiology | 3 | 2014 | 25 | 0.920 |
Why?
|
| Social Behavior | 5 | 2017 | 306 | 0.920 |
Why?
|
| Behavior, Animal | 8 | 2019 | 709 | 0.900 |
Why?
|
| Motor Disorders | 1 | 2022 | 6 | 0.880 |
Why?
|
| Epilepsies, Partial | 1 | 2023 | 111 | 0.850 |
Why?
|
| Epilepsy, Absence | 1 | 2022 | 35 | 0.840 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 72 | 0.820 |
Why?
|
| Disabled Persons | 1 | 2022 | 121 | 0.780 |
Why?
|
| Brain Ischemia | 2 | 2014 | 292 | 0.770 |
Why?
|
| Brain-Derived Neurotrophic Factor | 7 | 2014 | 176 | 0.720 |
Why?
|
| Brain | 7 | 2023 | 4113 | 0.630 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 502 | 0.560 |
Why?
|
| Protein Precursors | 2 | 2017 | 240 | 0.550 |
Why?
|
| Stroke | 2 | 2014 | 1144 | 0.520 |
Why?
|
| Depressive Disorder, Major | 2 | 2011 | 441 | 0.510 |
Why?
|
| Down-Regulation | 4 | 2017 | 2074 | 0.490 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2013 | 15 | 0.480 |
Why?
|
| Reward | 5 | 2010 | 169 | 0.480 |
Why?
|
| Autistic Disorder | 1 | 2017 | 319 | 0.470 |
Why?
|
| Bradycardia | 1 | 2013 | 70 | 0.450 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2012 | 9 | 0.450 |
Why?
|
| Fear | 1 | 2014 | 254 | 0.430 |
Why?
|
| Avoidance Learning | 3 | 2012 | 94 | 0.430 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 538 | 0.420 |
Why?
|
| Anxiety | 4 | 2020 | 1179 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 854 | 0.400 |
Why?
|
| Anticonvulsants | 3 | 2023 | 431 | 0.400 |
Why?
|
| Adenylyl Cyclases | 2 | 2008 | 87 | 0.400 |
Why?
|
| Adaptation, Physiological | 4 | 2011 | 360 | 0.390 |
Why?
|
| Delirium | 1 | 2013 | 207 | 0.390 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2013 | 253 | 0.390 |
Why?
|
| Affect | 2 | 2023 | 288 | 0.380 |
Why?
|
| Antidepressive Agents | 6 | 2011 | 332 | 0.380 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 7222 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1491 | 0.340 |
Why?
|
| Electrocardiography | 1 | 2013 | 1145 | 0.300 |
Why?
|
| Mice | 26 | 2022 | 34495 | 0.300 |
Why?
|
| Animals | 31 | 2022 | 59536 | 0.300 |
Why?
|
| Electroencephalography | 5 | 2023 | 898 | 0.290 |
Why?
|
| Anxiety Disorders | 3 | 2020 | 666 | 0.260 |
Why?
|
| Glutamic Acid | 3 | 2017 | 309 | 0.260 |
Why?
|
| Brain Mapping | 2 | 2023 | 644 | 0.250 |
Why?
|
| Psychiatry | 1 | 2008 | 307 | 0.250 |
Why?
|
| Depressive Disorder | 1 | 2008 | 557 | 0.240 |
Why?
|
| Neurons | 8 | 2017 | 2287 | 0.240 |
Why?
|
| Actigraphy | 1 | 2023 | 54 | 0.220 |
Why?
|
| Dopamine | 4 | 2008 | 312 | 0.220 |
Why?
|
| Neurophysiology | 1 | 2022 | 20 | 0.220 |
Why?
|
| Analysis of Variance | 8 | 2011 | 2307 | 0.210 |
Why?
|
| Neurotransmitter Agents | 2 | 2014 | 159 | 0.210 |
Why?
|
| Calcium | 1 | 2008 | 1537 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 14 | 2014 | 6942 | 0.200 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.190 |
Why?
|
| Ataxia | 1 | 2022 | 176 | 0.190 |
Why?
|
| Scalp | 1 | 2022 | 156 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2054 | 0.190 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2021 | 59 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2010 | 123 | 0.180 |
Why?
|
| Pentylenetetrazole | 1 | 2019 | 29 | 0.180 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 12 | 0.180 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2019 | 28 | 0.180 |
Why?
|
| Interpersonal Relations | 4 | 2011 | 290 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2011 | 703 | 0.170 |
Why?
|
| Dominance-Subordination | 5 | 2010 | 19 | 0.170 |
Why?
|
| Cocaine | 3 | 2009 | 233 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 181 | 0.160 |
Why?
|
| Escape Reaction | 2 | 2008 | 15 | 0.160 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.160 |
Why?
|
| Male | 22 | 2023 | 123000 | 0.160 |
Why?
|
| Dopamine Antagonists | 2 | 2014 | 52 | 0.140 |
Why?
|
| Deep Brain Stimulation | 1 | 2021 | 348 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 2063 | 0.140 |
Why?
|
| Dopamine Agonists | 2 | 2014 | 85 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 7702 | 0.130 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2014 | 3 | 0.130 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 52 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 88 | 0.120 |
Why?
|
| Signal Transduction | 9 | 2011 | 11965 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 443 | 0.120 |
Why?
|
| Female | 12 | 2023 | 141928 | 0.120 |
Why?
|
| Rats | 7 | 2014 | 6086 | 0.120 |
Why?
|
| Comorbidity | 1 | 2020 | 2352 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2011 | 1555 | 0.110 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 52 | 0.110 |
Why?
|
| Sex Factors | 3 | 2013 | 2139 | 0.110 |
Why?
|
| Neurology | 1 | 2013 | 113 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2009 | 1549 | 0.100 |
Why?
|
| Bromodeoxyuridine | 2 | 2010 | 139 | 0.100 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2008 | 46 | 0.100 |
Why?
|
| Dopaminergic Neurons | 1 | 2011 | 51 | 0.100 |
Why?
|
| Sucrose | 2 | 2009 | 64 | 0.100 |
Why?
|
| Swimming | 2 | 2008 | 27 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2017 | 1620 | 0.100 |
Why?
|
| Social Isolation | 2 | 2009 | 64 | 0.100 |
Why?
|
| Neuropsychiatry | 1 | 2011 | 13 | 0.100 |
Why?
|
| Food Preferences | 2 | 2009 | 119 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2008 | 1399 | 0.100 |
Why?
|
| Hypothalamus | 2 | 2010 | 255 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2017 | 6150 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2010 | 104 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2010 | 16 | 0.090 |
Why?
|
| Melanocortins | 1 | 2010 | 13 | 0.090 |
Why?
|
| Fluoxetine | 4 | 2012 | 43 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1038 | 0.090 |
Why?
|
| Morphine | 1 | 2011 | 308 | 0.090 |
Why?
|
| Neural Inhibition | 1 | 2010 | 147 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 250 | 0.090 |
Why?
|
| Amygdala | 1 | 2010 | 127 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2014 | 5710 | 0.090 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 64 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 471 | 0.090 |
Why?
|
| Radiography | 1 | 2013 | 1904 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2008 | 7 | 0.090 |
Why?
|
| Quality of Life | 1 | 2023 | 4532 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2009 | 365 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 280 | 0.080 |
Why?
|
| Immobility Response, Tonic | 1 | 2008 | 5 | 0.080 |
Why?
|
| Receptor, trkB | 1 | 2008 | 53 | 0.080 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 86 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 229 | 0.080 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2009 | 110 | 0.080 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2008 | 19 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 2008 | 66 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 304 | 0.080 |
Why?
|
| Neuroimmunomodulation | 1 | 2008 | 66 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 109 | 0.080 |
Why?
|
| Leptin | 1 | 2010 | 295 | 0.080 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 79 | 0.080 |
Why?
|
| Helplessness, Learned | 1 | 2007 | 7 | 0.080 |
Why?
|
| Periaqueductal Gray | 1 | 2007 | 13 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2010 | 238 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2008 | 88 | 0.080 |
Why?
|
| Nerve Net | 1 | 2010 | 257 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2008 | 154 | 0.070 |
Why?
|
| Motor Activity | 2 | 2008 | 693 | 0.070 |
Why?
|
| Phenotype | 2 | 2008 | 6295 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2008 | 764 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2010 | 629 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2008 | 298 | 0.070 |
Why?
|
| Limbic System | 1 | 2006 | 29 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 516 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 980 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 614 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 1648 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 1618 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2009 | 492 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2009 | 612 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 231 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 330 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 4744 | 0.060 |
Why?
|
| Benzamides | 1 | 2009 | 1832 | 0.060 |
Why?
|
| Hippocampus | 1 | 2010 | 915 | 0.060 |
Why?
|
| Adult | 3 | 2023 | 77950 | 0.060 |
Why?
|
| Emotions | 2 | 2023 | 562 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2007 | 376 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2011 | 862 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6009 | 0.060 |
Why?
|
| Pyridines | 1 | 2009 | 1244 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1450 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 1879 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 639 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2009 | 1664 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 4143 | 0.050 |
Why?
|
| Estradiol | 1 | 2004 | 748 | 0.050 |
Why?
|
| Gene Expression Regulation | 5 | 2009 | 4053 | 0.040 |
Why?
|
| Artifacts | 1 | 2021 | 532 | 0.040 |
Why?
|
| Aged | 2 | 2014 | 70117 | 0.040 |
Why?
|
| Imipramine | 2 | 2009 | 29 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 1682 | 0.040 |
Why?
|
| Young Adult | 2 | 2013 | 21445 | 0.040 |
Why?
|
| Obesity | 1 | 2010 | 2884 | 0.040 |
Why?
|
| Middle Aged | 2 | 2013 | 86204 | 0.030 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 716 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 4938 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 7226 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 155 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2216 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 32848 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2010 | 1819 | 0.030 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2012 | 56 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 650 | 0.030 |
Why?
|
| Maze Learning | 1 | 2012 | 132 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2009 | 2450 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 5159 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2014 | 324 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 2508 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 3536 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 634 | 0.020 |
Why?
|
| Histones | 2 | 2009 | 1466 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2011 | 18 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 37905 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2011 | 59 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 106 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2011 | 116 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 252 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2010 | 27 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2009 | 14 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2009 | 35 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 388 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 70 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2009 | 33 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 245 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 777 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 46 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 445 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 1581 | 0.020 |
Why?
|
| S Phase | 1 | 2010 | 281 | 0.020 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2009 | 32 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2009 | 65 | 0.020 |
Why?
|
| Phenanthridines | 1 | 2008 | 10 | 0.020 |
Why?
|
| Self Administration | 1 | 2008 | 50 | 0.020 |
Why?
|
| Lac Operon | 1 | 2009 | 122 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 2008 | 48 | 0.020 |
Why?
|
| Enkephalins | 1 | 2008 | 23 | 0.020 |
Why?
|
| Sincalide | 1 | 2008 | 37 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2008 | 45 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2008 | 31 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 694 | 0.020 |
Why?
|
| Orexins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 663 | 0.020 |
Why?
|
| Affective Symptoms | 1 | 2009 | 102 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 12926 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2009 | 162 | 0.020 |
Why?
|
| Benzazepines | 1 | 2008 | 108 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2009 | 330 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 129 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 671 | 0.020 |
Why?
|
| Lithium Compounds | 1 | 2007 | 15 | 0.020 |
Why?
|
| Substance P | 1 | 2007 | 71 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 35 | 0.020 |
Why?
|
| Lithium | 1 | 2007 | 71 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 262 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 32 | 0.020 |
Why?
|
| Locomotion | 1 | 2007 | 84 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 163 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 442 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 518 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 595 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 161 | 0.020 |
Why?
|
| Acetylation | 1 | 2007 | 508 | 0.020 |
Why?
|
| Mutation | 3 | 2012 | 15179 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2007 | 426 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 483 | 0.020 |
Why?
|
| Densitometry | 1 | 2004 | 45 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2010 | 769 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2004 | 300 | 0.020 |
Why?
|
| Cricetulus | 1 | 2004 | 205 | 0.020 |
Why?
|
| CHO Cells | 1 | 2004 | 311 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 3154 | 0.020 |
Why?
|
| COS Cells | 1 | 2004 | 377 | 0.020 |
Why?
|
| Aggression | 1 | 2006 | 252 | 0.010 |
Why?
|
| RNA | 1 | 2009 | 1013 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 706 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3639 | 0.010 |
Why?
|
| Chromatin | 1 | 2007 | 942 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 1582 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1764 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 3254 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 5637 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 2171 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2007 | 1616 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 5270 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2086 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 5114 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 7548 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 31252 | 0.010 |
Why?
|